Development of Infectious Bovine Rhinotracheitis Live Virus Vaccine

Rapid onset of protection against infectious bovine rhinotracheitis with a modified-live virus multivalent vaccine.

This study provides evidence that subcutaneous vaccination of cattle with a commercially available modified-live virus combination vaccine can help reduce clinical signs associated with infectious bovine rhinotracheitis infections in feedlot animals vaccinated at the time of arrival. Calves vaccinated 72 or 96 hours before challenge had reduced clinical signs, lower body temperatures, lower vir...

Isolation, Characterization and Standardization of New Infectious Bursal Disease Virus for Development of a Live Vaccine

Background and Aims: Infectious bursal disease (IBD) is an acute contagious viral disease of birds worldwide. The causative virus induces a persistent immune suppression following destroy B lymphocytes precursors in bursal lymphoid follicles. Vaccination is the main strategy for prevention of the disease in commercial poultry industry. Materials and Methods: To produce a live vaccine against th...

Susceptibility of bovine macrophages to infectious bovine rhinotracheitis virus infection.

Infectious bovine rhinotracheitis virus replicated in cultured bovine alveolar macrophages (AM). However, yields of infectious virus were low, with maximum titers approximately 100 times that of the residual inoculum. Immunofluorescence and electron microscopic studies indicated that the majority of macrophages produced viral antigen, but after infection at a multiplicity of 0.1, only 4.1% of A...

Infectious bovine rhinotracheitis.

Cattle exhibiting the vulvovaginitis form of the IBR complex are sexually mature females that do not appear ill. Signs of IPV include a thick yellow to brown vulvar discharge that attaches to the vulvar tuft of hair. The vulva is swollen and the vulvar and vaginal lining is reddened, dying and/or contains small whitish-colored pustules. The vaginal-vulvar infection causes irritation, exhibited ...

Use of Sodium Alginate Adjuvant in Preparation of a Formalin Killed Vaccine Against Infectious Bovine Rhinotracheitis